Literature DB >> 32051482

The association between predicted inflammatory status and colorectal adenoma.

Sejin Kim1, Sihan Song1, Young Sun Kim2, Sun Young Yang3, Jung Eun Lee4,5.   

Abstract

We developed a diet and lifestyle score based on high sensitivity C-reactive protein (hsCRP), and investigated its association with odds of adenoma. We performed stepwise linear regression to develop the predicted hsCRP score among 23,330 participants in the Health Examinee Study and examined its association with colorectal adenoma among 1,711 participants in a cross-sectional study of colorectal adenoma. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) of colorectal adenoma using logistic regression models. Variances in hsCRP explained by body mass index were 61.1% in men and 64.5% in women in the prediction model. The increasing predicted hsCRP score was positively associated with colorectal adenoma (ORquartile 4 VS quartile 1 1.71, 95% CI: 1.12-2.62; Ptrend = 0.011 in men; ORquartile 4 VS quartile 1 2.86, 95% CI: 1.26-6.49; Ptrend = 0.019 in women). In subgroups, the associations differed by age and menopausal status among women, with stronger associations among women aged less than 50 years (OR≥median VS <median 3.74, 95% CI: 1.77-7.90, p for interaction 0.014) or premenopausal women (OR≥median vs <median 4.21, 95% CI: 2.12-8.36, p for interaction <0.001). The associations were more pronounced in the advanced or distal colon/rectum in men and in the advanced or proximal colon in women. The associations were attenuated after further adjustment for body mass index. In conclusion, we found that the predicted hsCRP score was positively associated with colorectal adenoma, suggesting that diet and lifestyle lowering inflammation may be a strategy to prevent colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32051482      PMCID: PMC7016133          DOI: 10.1038/s41598-020-59271-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

Review 1.  Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review.

Authors:  Janett Barbaresko; Manja Koch; Matthias B Schulze; Ute Nöthlings
Journal:  Nutr Rev       Date:  2013-06-13       Impact factor: 7.110

2.  Development and Validation of an Empirical Dietary Inflammatory Index.

Authors:  Fred K Tabung; Stephanie A Smith-Warner; Jorge E Chavarro; Kana Wu; Charles S Fuchs; Frank B Hu; Andrew T Chan; Walter C Willett; Edward L Giovannucci
Journal:  J Nutr       Date:  2016-06-29       Impact factor: 4.798

Review 3.  Intestinal inflammation and cancer.

Authors:  Thomas A Ullman; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 4.  Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials.

Authors:  Michael V Fedewa; Elizabeth D Hathaway; Christie L Ward-Ritacco
Journal:  Br J Sports Med       Date:  2016-07-21       Impact factor: 13.800

Review 5.  C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.

Authors:  Bo Zhou; Bin Shu; Jue Yang; Jing Liu; Tao Xi; Yingying Xing
Journal:  Cancer Causes Control       Date:  2014-07-23       Impact factor: 2.506

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Designing and developing a literature-derived, population-based dietary inflammatory index.

Authors:  Nitin Shivappa; Susan E Steck; Thomas G Hurley; James R Hussey; James R Hébert
Journal:  Public Health Nutr       Date:  2013-08-14       Impact factor: 4.022

8.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

9.  Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.

Authors:  Justyna Godos; Antonio Biondi; Fabio Galvano; Francesco Basile; Salvatore Sciacca; Edward L Giovannucci; Giuseppe Grosso
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

10.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Eun Sook Lee
Journal:  Cancer Res Treat       Date:  2018-03-21       Impact factor: 4.679

View more
  4 in total

1.  Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention.

Authors:  Jarosław Wierzbicki; Artur Lipiński; Iwona Bednarz-Misa; Łukasz Lewandowski; Katarzyna Neubauer; Paulina Lewandowska; Małgorzata Krzystek-Korpacka
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

2.  Association Between Diet Quality and Prevalence of Obesity, Dyslipidemia, and Insulin Resistance Among Filipino Immigrant Women in Korea: The Filipino Women's Diet and Health Study.

Authors:  Hee Sun Kim; Heejin Lee; Sherlyn Mae P Provido; Minji Kang; Grace H Chung; Sangmo Hong; Sung Hoon Yu; Chang Beom Lee; Jung Eun Lee
Journal:  Front Public Health       Date:  2021-07-01

3.  Association of Coffee Consumption and Its Types According to Addition of Sugar and Creamer with Metabolic Syndrome Incidence in a Korean Population from the Health Examinees (HEXA) Study.

Authors:  Li-Juan Tan; Hye Joo Jeon; SoHyun Park; Seong-Ah Kim; Kyungjoon Lim; Sangwon Chung; Pahn-Shick Chang; Jong-Koo Lee; Daehee Kang; Sangah Shin
Journal:  Nutrients       Date:  2021-03-12       Impact factor: 5.717

Review 4.  Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer.

Authors:  Luiz F S Oliveira; Danilo Predes; Helena L Borges; Jose G Abreu
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.